Form 4: RenovoRx CFO Mark Voll Buys Shares, Warrants

RenovoRx's Chief Financial Officer, Mark Voll, acquired 97,200 common shares and 48,600 warrants in a private placement.

Summary

• Mark Voll, Chief Financial Officer of RenovoRx, Inc. (RNXT), reported an acquisition of securities.
• On March 20, 2026, Mr. Voll acquired 97,200 shares of common stock in a private placement.
• The aggregate purchase price for these common shares was $100,000.
• Concurrently, Mr. Voll also acquired 48,600 warrants in the same private placement.
• The warrants have an exercise price of $1.9326 per share.
• These warrants are exercisable immediately upon issuance.
• The warrants expire on the earlier of March 30, 2029, or 30 days following the date RenovoRx reports at least $1.5 million in product sales revenue for any calendar quarter.
• All acquired securities are beneficially owned indirectly through the Voll Family Trust DTD 6/23/2010, with Mark Voll as Trustee.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive signal. The CFO's direct investment, especially in a private placement, demonstrates significant confidence in the company's valuation and future prospects.

Positives

• The Chief Financial Officer's direct investment in the company's common stock and warrants signals strong insider confidence in RenovoRx's future prospects and valuation.
• The acquisition through a private placement indicates a strategic investment by management, aligning their interests with those of other shareholders.

Industry Context

StockSavvy.ai notes that insider buying, particularly by a Chief Financial Officer who has deep insight into a company's financial health, is often interpreted by the market as a positive signal. It suggests that management believes the company's stock is undervalued or expects significant positive developments in the future, aligning their personal financial interests with shareholder value creation.

Related Party Transactions

• The acquisition of common stock and warrants by Mark Voll, the Chief Financial Officer, constitutes a related party transaction as it involves a key executive of the company.

Stakeholder Impact

• Shareholders: The insider purchase may instill greater confidence among existing and potential shareholders, suggesting that management believes in the company's growth trajectory and intrinsic value.
• Employees: A strong signal of management confidence can positively impact employee morale and alignment with company goals.

Key Dates

Recommendation

A seasoned investor or institution would view the Chief Financial Officer's significant personal investment in RenovoRx's common stock and warrants, acquired through a private placement, as a strong indicator of management's conviction in the company's future performance and potential for appreciation. Insider buying often precedes positive developments or reflects a belief that the stock is currently undervalued. This direct alignment of interests suggests a 'buy' recommendation, signaling confidence in the company's trajectory.

Keywords

RenovoRx, RNXT, Mark Voll, CFO, Insider Buying, Form 4, Private Placement, Common Stock, Warrants, Beneficial Ownership, SEC Filing